Baxter International Inc (BAX)
32.99
+0.36
(+1.10%)
USD |
NYSE |
Nov 21, 16:00
33.01
+0.02
(+0.06%)
After-Hours: 20:00
Baxter International Enterprise Value: 28.43B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 28.43B |
| November 20, 2024 | 28.25B |
| November 19, 2024 | 28.19B |
| November 18, 2024 | 28.44B |
| November 15, 2024 | 27.90B |
| November 14, 2024 | 27.77B |
| November 13, 2024 | 28.25B |
| November 12, 2024 | 28.86B |
| November 11, 2024 | 29.06B |
| November 08, 2024 | 29.27B |
| November 07, 2024 | 29.99B |
| November 06, 2024 | 30.02B |
| November 05, 2024 | 30.02B |
| November 04, 2024 | 29.86B |
| November 01, 2024 | 29.90B |
| October 31, 2024 | 29.81B |
| October 30, 2024 | 29.89B |
| October 29, 2024 | 29.96B |
| October 28, 2024 | 29.97B |
| October 25, 2024 | 29.95B |
| October 24, 2024 | 30.33B |
| October 23, 2024 | 30.20B |
| October 22, 2024 | 30.26B |
| October 21, 2024 | 30.25B |
| October 18, 2024 | 30.40B |
| Date | Value |
|---|---|
| October 17, 2024 | 30.29B |
| October 16, 2024 | 30.35B |
| October 15, 2024 | 30.29B |
| October 14, 2024 | 30.43B |
| October 11, 2024 | 30.24B |
| October 10, 2024 | 30.49B |
| October 09, 2024 | 30.90B |
| October 08, 2024 | 30.53B |
| October 07, 2024 | 29.84B |
| October 04, 2024 | 30.12B |
| October 03, 2024 | 29.49B |
| October 02, 2024 | 29.95B |
| October 01, 2024 | 30.43B |
| September 30, 2024 | 30.97B |
| September 27, 2024 | 30.73B |
| September 26, 2024 | 30.62B |
| September 25, 2024 | 30.43B |
| September 24, 2024 | 30.76B |
| September 23, 2024 | 30.77B |
| September 20, 2024 | 30.51B |
| September 19, 2024 | 30.65B |
| September 18, 2024 | 30.96B |
| September 17, 2024 | 31.18B |
| September 16, 2024 | 31.41B |
| September 13, 2024 | 31.14B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
26.86B
Minimum
Oct 12 2023
59.68B
Maximum
Feb 09 2022
40.63B
Average
42.38B
Median
Nov 11 2021
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| Haemonetics Corp | 5.216B |
| Accuray Inc | 301.10M |
| Masimo Corp | 9.669B |
| Insulet Corp | 18.87B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 140.00M |
| Revenue (Quarterly) | 2.699B |
| Total Expenses (Quarterly) | 2.549B |
| EPS Diluted (Quarterly) | 0.27 |
| Gross Profit Margin (Quarterly) | 38.27% |
| Profit Margin (Quarterly) | 5.19% |
| Earnings Yield | 0.61% |
| Operating Earnings Yield | 3.30% |
| Normalized Earnings Yield | 1.406 |